Gene · 926
Papers3,225
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,225
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular CIRP induces CD4CD8αα intraepithelial lymphocyte cytotoxicity in sepsis. | Mol Med | 2024 | 38302880 | PubTator, text mining | PubMed |
| Integrative single-cell analysis: dissecting CD8 + memory cell roles in LUAD and COVID-19 via eQTLs and Mendelian Randomization. | Hereditas | 2024 | 38297377 | PubTator, text mining | PubMed |
| BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates. | Eur J Med Res | 2024 | 38297320 | PubTator, text mining | PubMed |
| Clinical and immunological relevance of SLAMF6 expression in the tumor microenvironment of breast cancer and melanoma. | Sci Rep | 2024 | 38287061 | PubTator, text mining | PubMed |
| Unraveling T cell exhaustion in the immune microenvironment of osteosarcoma via single-cell RNA transcriptome. | Cancer Immunol Immunother | 2024 | 38280005 | PubTator, text mining | PubMed |
| Development and validation of an immunogenic cell death-related prognostic model, and landscape of the tumor immune microenvironment in glioblastoma. | Genes Dis | 2024 | 38274376 | PubTator, text mining | PubMed |
| Multimodal profiling of chordoma immunity reveals distinct immune contextures. | J Immunother Cancer | 2024 | 38272563 | PubTator, text mining | PubMed |
| Regulation of tumor metastasis and CD8+ T cells infiltration by circRNF216/miR-576-5p/ZC3H12C axis in colorectal cancer. | Cell Mol Biol Lett | 2024 | 38267865 | PubTator, text mining | PubMed |
| Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity. | Nat Commun | 2024 | 38267413 | PubTator, text mining | PubMed |
| Immunogenic cell death-related classification reveals prognosis and effectiveness of immunotherapy in breast cancer. | Sci Rep | 2024 | 38263419 | PubTator, text mining | PubMed |
| Advancing Esophageal Cancer Treatment: Immunotherapy in Neoadjuvant and Adjuvant Settings. | Cancers (Basel) | 2024 | 38254805 | PubTator, text mining | PubMed |
| Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+ regulatory T cells: Implications for prognosis and therapy prediction. | Clin Transl Med | 2024 | 38239097 | PubTator, text mining | PubMed |
| Immune characteristics of kidney transplant recipients with acute respiratory distress syndrome induced by COVID-19 at single-cell resolution. | Respir Res | 2024 | 38238762 | PubTator, text mining | PubMed |
| Type 1 immunity enables neonatal thymic ILC1 production. | Sci Adv | 2024 | 38232171 | PubTator, text mining | PubMed |
| When it rains, it pours: Early treatment with tecovirimat of cardiac complications associated with monkeypox infection in a person with HIV and previously undiagnosed Lyme disease. A case report. | Heliyon | 2024 | 38226256 | PubTator, text mining | PubMed |
| EPRIM: An approach of identifying cancer immune-related epigenetic regulators. | Mol Ther Nucleic Acids | 2024 | 38222302 | PubTator, text mining | PubMed |
| BIDCell: Biologically-informed self-supervised learning for segmentation of subcellular spatial transcriptomics data. | Nat Commun | 2024 | 38218939 | PubTator, text mining | PubMed |
| Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. | Nat Immunol | 2024 | 38212464 | PubTator, text mining | PubMed |
| Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer. | J Immunother Cancer | 2024 | 38199610 | PubTator, text mining | PubMed |
| Predicting patient outcomes after treatment with immune checkpoint blockade: A review of biomarkers derived from diverse data modalities. | Cell Genom | 2024 | 38190106 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/926/papers?page=8